Trial NCT00667277

View at ClinicalTrials.gov 
Org. Study IDs: GCO 07-0548-00103
Secondary IDs: MPD-RC 103 P01CA108671-01A2

Last trial update was posted on 2014-08-22

MeSH Interventions

Bevacizumab

MeSH Conditions

Primary Myelofibrosis

Other Conditions

Myelofibrosis

Stopping Reasons

lack of response activity in the setting of an unacceptable toxicity profile

Limitations And Caveats

The study was terminated due to lack of response activity in the setting of an unacceptable toxicity profile at the completion of the first stage.

Result Publications


Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID